Stepping Up 模式在基层2型糖尿病胰岛素启动中的整群随机对照试验
该整群随机对照试验在澳大利亚维多利亚州74家基层诊所比较Stepping Up照护模式与常规基层照护对2型糖尿病胰岛素启动及血糖控制的效果,共纳入266例患者随访12个月。结果显示干预组启动胰岛素比例更高、HbA1c改善更显著且达标率更高,抑郁症状未恶化,无严重低血糖事件报告。
要点
- Stepping Up模式使基层2型糖尿病胰岛素启动率从22%提升至70%。
- 干预组HbA1c平均多降低0.6%,达标率从19%升至36%。
- 干预未加重抑郁症状,心理健康评分略有改善,无严重低血糖。
核心结论
- Stepping Up照护模式与基层胰岛素启动率增加及HbA1c改善相关,且未恶化情绪健康。
研究设计与样本
- 整群随机对照试验,纳入澳大利亚维多利亚州74家基层诊所和266例2型糖尿病患者,随访12个月。
主要发现
- 12个月时干预组105/151(70%)启动胰岛素,对照组25/115(22%),比值比8.3(95%CI 4.5至15.4,P<0.001)。
- HbA1c组间平均差为-0.6%(95%CI -0.9%至-0.3%),有利于干预组。
- 达到目标HbA1c(≤7%(53 mmol/mol))者干预组54例(36%),对照组22例(19%),比值比2.2(95%CI 1.2至4.3,P=0.02)。
- 抑郁症状未恶化(PHQ-9:-1.1(3.5)对-0.1(2.9),P=0.05)。
- 心理健康评分组间平均变化差异0.04(95%CI 0.002至0.08,P=0.04),有利于干预组;躯体健康和糖尿病特异性痛苦无显著差异;无严重低血糖事件报告。
关键数值与推荐
- 纳入标准为HbA1c≥7.5%且已接受最大口服治疗。
- 主要终点为HbA1c变化;次要终点包括启动胰岛素比例、达标HbA1c比例及抑郁症状等变化。
临床怎么用
- 在基层糖尿病团队中可强化实践护士主导胰岛素启动的角色,并由具有糖尿病教育者资质的注册护士提供指导。
- 该模式可用于推动最大口服治疗下HbA1c≥7.5%患者的胰岛素启动,改善血糖控制而不加重情绪负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To compare the effectiveness of a novel model of care ("Stepping Up") with usual primary care in normalising insulin initiation for type 2 diabetes, leading to improved glycated haemoglobin (HbA1c) levels.Design Cluster randomised controlled trial.Setting Primary care practices in Victoria, Australia, with a practice nurse and at least one consenting eligible patient (HbA1c ≥7.5% with maximal oral treatment).Participants 266 patients with type 2 diabetes and 74 practices (mean cluster size 4 (range 1-8) patients), followed up for 12 months.Intervention The Stepping Up model of care intervention involved theory based change in practice systems and reorientation of the roles of health professionals in the primary care diabetes team. The core components were an enhanced role for the practice nurse in leading insulin initiation and mentoring by a registered nurse with diabetes educator credentials.Main outcome measures The primary endpoint was change in HbA1c. Secondary endpoints included the proportion of participants who transitioned to insulin, proportion who achieved target HbA1c, and a change in depressive symptoms (patient health questionnaire, PHQ-9), diabetes specific distress (problem areas in diabetes scale, PAID), and generic health status (assessment of quality of life instrument, AQoL-8D).Results HbA1c improved in both arms, with a clinically significant between arm difference (mean difference -0.6%, 95% confidence interval -0.9% to -0.3%), favouring the intervention. At 12 months, in intervention practices, 105/151 (70%) of participants had started insulin, compared with 25/115 (22%) in control practices (odds ratio 8.3, 95% confidence interval 4.5 to 15.4, P<0.001). Target HbA1c (≤7% (53 mmol/mol)) was achieved by 54 (36%) intervention participants and 22 (19%) control participants (odds ratio 2.2, 1.2 to 4.3, P=0.02). Depressive symptoms did not worsen at 12 months (PHQ-9: -1.1 (3.5) v -0.1 (2.9), P=0.05). A statistically significant difference was found between arms in the mean change in mental health (AQoL mental component summary: 0.04 (SD 0.16) v -0.002 (0.13), mean difference 0.04 (95% confidence interval 0.002 to 0.08), P=0.04), favouring the intervention, but no significant difference in physical health (AQoL physical component summary: 0.03 (0.15) v 0.02 (0.13)) nor diabetes specific distress (5.6 (15.5) v -2.4 (15.4)). No severe hypoglycaemia events were reported.Conclusions The Stepping Up model of care was associated with increased insulin initiation rates in primary care, and improvements in glycated haemoglobin without worsening emotional wellbeing.Trial registration Australian and New Zealand Clinical Trials Registry ACTRN12612001028897.
引用
- Furler J, O'Neal D, Speight J, et al. Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial. BMJ. 2017. PMID: 28274941. doi:10.1136/bmj.j783
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。